ADELAIDE, AUS, Oct 19, 2021 - (ACN Newswire via SEAPRWire.com) - Agilex Biolabs, the Australian regulated bioanalytical and toxicology laboratory facilities for clinical trials is presenting a new webinar entitled "Getting it right! Considerations for Immuno-oncology and Vaccine Studies and the Bioanalytical Tools used" in partnership with Outsourcing Clinical Trials (OCT).Agilex Biolabs' Director, Immunoassay, Kurt J. Sales (B.Sc; B.Sc (MED) Hons; M.Sc, Ph.D, PGCM) said:"Choosing the right bioanalytical platform for your immunology or vaccines clinical trial is critical to data collection. But navigating the intricate bioanalytical process and selection of assay platforms can be difficult. This webinar covers these platforms in detail and the selection process."Agilex Biolabs is the largest regulated bioanalytical laboratory in Australia with over 24 years' experience in early phase clinical trials with a track record of enabling the movement of new drug entities to market.Agilex Biolabs specialises in pharmacokinetics, pharmacodynamics, and biomarker evaluation, which is key to understanding the drug absorption, distribution, metabolism, and excretion as well as target engagement...